EUTM file information

018317758

LYVFIRLA


October 5, 2020

Trademark Summary

The trademark application LYVFIRLA was filed by Intercept Pharmaceuticals, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on November 3, 2020, and it was registered by office on February 10, 2021 without any oppositions.

The application was filed in English (French was selected as the second language).

Appointment and Replacement of representative of the trademark registration was recorded on January 4, 2021. Appointment and Replacement of representative of the trademark registration was recorded on February 15, 2021.


Goods And Services

  • The mark was filed in class 5 with following description of goods:
    1. Pharmaceutical preparations
    2. Pharmaceutical preparations for the treatment of liver diseases, disorders and conditions
    3. Pharmaceuticals for treating nonalcoholic steatohepatitis, non-alcoholic fatty liver disease, liver fibrosis, and liver cirrhosis.
Trademarkers